Cas 1415151-13-1,N<sub>2</sub>-(5-bromo-2-methoxypyridin-3-yl)-N<sub>4</sub>-cyclohexyl-5-nitropyrimidine-2,4-diamine

1415151-13-1

Post Buying Request

Basic information

Product Name: N₂-(5-bromo-2-methoxypyridin-3-yl)-N₄-cyclohexyl-5-nitropyrimidine-2,4-diamine
Synonyms: N₂-(5-bromo-2-methoxypyridin-3-yl)-N₄-cyclohexyl-5-nitropyrimidine-2,4-diamine
CAS NO:1415151-13-1
Molecular Formula:
Molecular Weight: 423.269
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N₂-(5-bromo-2-methoxypyridin-3-yl)-N₄-cyclohexyl-5-nitropyrimidine-2,4-diamine(CAS DataBase Reference)
NIST Chemistry Reference: N₂-(5-bromo-2-methoxypyridin-3-yl)-N₄-cyclohexyl-5-nitropyrimidine-2,4-diamine(1415151-13-1)
EPA Substance Registry System: N₂-(5-bromo-2-methoxypyridin-3-yl)-N₄-cyclohexyl-5-nitropyrimidine-2,4-diamine(1415151-13-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1415151-13-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1415151-13-1 Suppliers

Recommended suppliers

1415151-13-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1415151-13-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,5,1,5 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1415151-13:
(9*1)+(8*4)+(7*1)+(6*5)+(5*1)+(4*5)+(3*1)+(2*1)+(1*3)=111
111 % 10 = 1
So 1415151-13-1 is a valid CAS Registry Number.

1415151-13-1Upstream product

1415151-13-1Downstream Products

1415151-13-1Relevant academic research and scientific papers

PYRIDIN-2 (1H) -ONE DERIVATIVES USEFUL AS MEDICAMENTS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS, TRANSPLANT REJECTION, IMMUNE-MEDIATED AND INFLAMMATORY DISEASES

-

Page/Page column 82, (2012/12/13)

Compoundshaving the chemical structure of formula (I) are disclosed; as well as process for theirpreparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1415151-13-1